Stimcell Energetics (STME) Assets Growth (5y) (2016 - 2026)
Stimcell Energetics (STME) Assets Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -19.17% |
| Nov 30, 2025 | -11.74% |
| Aug 31, 2025 | -41.47% |
| May 31, 2025 | -33.17% |
| Feb 28, 2025 | -40.24% |
| Nov 30, 2024 | -37.53% |
| Aug 31, 2024 | -45.13% |
| May 31, 2024 | -24.70% |
| Feb 29, 2024 | -18.07% |
| Nov 30, 2023 | -24.80% |
| Aug 31, 2023 | 3.70% |
| May 31, 2023 | 17.94% |
| Feb 28, 2023 | -38.86% |
| Nov 30, 2022 | -42.32% |
| Aug 31, 2022 | -44.29% |
| May 31, 2022 | -32.44% |
| Feb 28, 2022 | -30.35% |
| May 31, 2021 | -27.94% |
| May 31, 2019 | 175.48% |
| May 31, 2018 | 32.75% |